Correlation
The correlation between ADMA and VRT is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
ADMA vs. VRT
Compare and contrast key facts about ADMA Biologics, Inc. (ADMA) and Vertiv Holdings Co. (VRT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ADMA or VRT.
Performance
ADMA vs. VRT - Performance Comparison
Loading data...
Key characteristics
ADMA:
1.64
VRT:
0.08
ADMA:
2.49
VRT:
0.56
ADMA:
1.32
VRT:
1.08
ADMA:
3.42
VRT:
0.05
ADMA:
6.90
VRT:
0.10
ADMA:
15.74%
VRT:
26.95%
ADMA:
67.19%
VRT:
73.54%
ADMA:
-91.28%
VRT:
-71.24%
ADMA:
-19.05%
VRT:
-29.65%
Fundamentals
ADMA:
$4.74B
VRT:
$41.62B
ADMA:
$0.84
VRT:
$1.70
ADMA:
23.62
VRT:
63.81
ADMA:
0.00
VRT:
0.86
ADMA:
10.31
VRT:
4.95
ADMA:
12.64
VRT:
15.50
ADMA:
$459.38M
VRT:
$8.41B
ADMA:
$241.40M
VRT:
$3.05B
ADMA:
$158.29M
VRT:
$1.46B
Returns By Period
In the year-to-date period, ADMA achieves a 15.69% return, which is significantly higher than VRT's -4.96% return.
ADMA
15.69%
-16.64%
-1.34%
109.28%
113.11%
43.24%
8.63%
VRT
-4.96%
26.41%
-15.35%
5.66%
114.36%
53.46%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ADMA vs. VRT — Risk-Adjusted Performance Rank
ADMA
VRT
ADMA vs. VRT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and Vertiv Holdings Co. (VRT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
ADMA vs. VRT - Dividend Comparison
ADMA has not paid dividends to shareholders, while VRT's dividend yield for the trailing twelve months is around 0.12%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
ADMA ADMA Biologics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VRT Vertiv Holdings Co. | 0.12% | 0.10% | 0.05% | 0.07% | 0.04% | 0.05% |
Drawdowns
ADMA vs. VRT - Drawdown Comparison
The maximum ADMA drawdown since its inception was -91.28%, which is greater than VRT's maximum drawdown of -71.24%. Use the drawdown chart below to compare losses from any high point for ADMA and VRT.
Loading data...
Volatility
ADMA vs. VRT - Volatility Comparison
ADMA Biologics, Inc. (ADMA) and Vertiv Holdings Co. (VRT) have volatilities of 14.61% and 14.15%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
ADMA vs. VRT - Financials Comparison
This section allows you to compare key financial metrics between ADMA Biologics, Inc. and Vertiv Holdings Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ADMA vs. VRT - Profitability Comparison
ADMA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, ADMA Biologics, Inc. reported a gross profit of 61.10M and revenue of 114.80M. Therefore, the gross margin over that period was 53.2%.
VRT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Vertiv Holdings Co. reported a gross profit of 686.50M and revenue of 2.04B. Therefore, the gross margin over that period was 33.7%.
ADMA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, ADMA Biologics, Inc. reported an operating income of 34.88M and revenue of 114.80M, resulting in an operating margin of 30.4%.
VRT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Vertiv Holdings Co. reported an operating income of 290.70M and revenue of 2.04B, resulting in an operating margin of 14.3%.
ADMA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, ADMA Biologics, Inc. reported a net income of 26.90M and revenue of 114.80M, resulting in a net margin of 23.4%.
VRT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Vertiv Holdings Co. reported a net income of 164.50M and revenue of 2.04B, resulting in a net margin of 8.1%.